Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Mar 9, 2026, 4:00 PM EDT
1.220
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:26 PM EDT
Bone Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 3 | 2 | 2 | 3 | 36 | |
| Market Cap Growth | -12.84% | 12.38% | -4.06% | -24.75% | -91.19% | -84.17% | |
| Enterprise Value | -3 | -3 | -1 | -2 | -2 | 49 | |
| Last Close Price | 1.22 | 1.45 | 5.64 | 27.12 | 301.97 | 5068.80 | |
| PB Ratio | 0.41 | 0.48 | 0.67 | 0.83 | 0.54 | 5.54 | |
| P/TBV Ratio | 0.41 | 0.48 | 0.67 | 0.83 | 0.54 | 5.54 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.95 | -1.04 | -1.27 | -1.01 | |
| Net Debt / FCF Ratio | 1.98 | 1.98 | 0.81 | 0.32 | 2.11 | 5.43 | |
| Quick Ratio | 12.77 | 12.77 | 8.80 | 3.64 | 2.96 | 66.81 | |
| Current Ratio | 13.85 | 13.85 | 10.22 | 4.50 | 3.33 | 66.81 | |
| Return on Equity (ROE) | -70.17% | -70.17% | -128.71% | -202.15% | -23.71% | - | |
| Return on Assets (ROA) | -41.87% | -41.87% | -69.40% | -96.34% | -30.20% | - | |
| Return on Capital Employed (ROCE) | -60.20% | -60.20% | -121.10% | -324.40% | -61.60% | -16.80% | |
| Earnings Yield | -141.95% | -119.43% | -177.53% | -370.63% | -46.27% | -4.42% | |
| FCF Yield | -122.87% | -103.38% | -178.07% | -395.77% | -111.16% | -3.37% | |
| Buyback Yield / Dilution | -364.45% | -364.45% | -476.80% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.